Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
9.05
+0.17 (1.91%)
Apr 30, 2026, 1:21 PM EDT - Market open
Rallybio Market Cap
Rallybio has a market cap or net worth of $47.87 million as of April 30, 2026. Its market cap has increased by 325.77% in one year.
Market Cap
47.87M
Enterprise Value
-7.59M
1-Year Change
325.77%
Ranking
Category
Stock Price
$9.05
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $47.87M, a decrease of -88.20%. That is a compound annual growth rate of -36.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 46.97M | 62.07% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 53.48M |
| Entera Bio | 52.22M |
| Radiopharm Theranostics | 50.96M |
| Telomir Pharmaceuticals | 50.02M |
| Nutriband | 47.53M |
| Xilio Therapeutics | 47.47M |
| Hyperion DeFi | 47.28M |
| Atossa Therapeutics | 46.67M |